Relapsed ALCL (ALK-1 Positive) Post Autologous Transplant
1 clinical trials · Condition
◉ Watch Relapsed ALCL (ALK-1 Positive) Post Autologous Transplant
| Record | Firm | Date |
|---|---|---|
| Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma (NCT00901147) | Singapore General Hospital | 2009-11-01 |
Track Relapsed ALCL (ALK-1 Positive) Post Autologous Transplant automatically
Every clearance here is in the API, with alerts when new ones post.